Göran Smedegård
Direktor/Vorstandsmitglied bei Axcentua Pharmaceuticals AB
Profil
Göran Smedegård is the founder of Innoventus Project AB.
He is currently working as a Director at Axcentua Pharmaceuticals AB since 2009.
Previously, he worked as a Licensing Director at AstraZeneca AB, Director-Business Development at Pharmacia AB, and Vice President-Business & Commercial Development at Orexo AB.
Aktive Positionen von Göran Smedegård
| Unternehmen | Position | Beginn |
|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 17.09.2009 |
Ehemalige bekannte Positionen von Göran Smedegård
| Unternehmen | Position | Ende |
|---|---|---|
| Pharmacia AB | Corporate Officer/Principal | 15.01.2009 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Innoventus Project AB
 Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Gründer | - |
| OREXO AB | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OREXO AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
Innoventus Project AB
Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |
| Pharmacia AB | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
